Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neumora Therapeutics, Inc. - Common Stock (NQ: NMRA )

1.800 +0.090 (+5.26%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,137,466
Open 1.720
Bid (Size) 1.740 (3)
Ask (Size) 1.810 (4)
Prev. Close 1.710
Today's Range 1.670 - 1.830
52wk Range 1.600 - 21.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ROSEN, A RANKED AND LEADING FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA
From The Rosen Law Firm PA
Via GlobeNewswire
NMRA Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors That a Securities Fraud Class Action Lawsuit Has Been Filed
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal

Performance

YTD
-8.63%
-8.63%
1 Month
-13.46%
-13.46%
3 Month
-81.52%
-81.52%
6 Month
-84.59%
-84.59%
1 Year
-90.44%
-90.44%

More News

Read More
NMRA Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors That a Securities Fraud Class Action Lawsuit Has Been Filed
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal
Lowey Dannenberg Notifies Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Neumora Therapeutics, Inc. (NMRA) Investors: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Neumora Therapeutics, Inc. (NMRA) Investors: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
NMRA INVESTORS: Kirby McInerney LLP Reminds Neumora Therapeutics, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via Business Wire
Lowey Dannenberg Notifies Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
NEUMORA THERAPEUTICS, INC. (NASDAQ: NMRA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Neumora Therapeutics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
NMRA Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges NMRA Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NMRA Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges NMRA Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
NMRA Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Neumora Therapeutics, Inc. (NMRA)
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal
NMRA Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Neumora Therapeutics, Inc. (NMRA)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Kessler Topaz Meltzer & Check, LLP Class Action Announcement NMRA: A Securities Fraud Class Action Lawsuit Was Filed Against Neumora Therapeutics, Inc. (NMRA)
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Lowey Dannenberg Notifies Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA
From The Rosen Law Firm PA
Via GlobeNewswire
Class Action Announcement for Neumora Therapeutics, Inc. (NMRA): Kessler Topaz Meltzer & Check, LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Neumora Therapeutics, Inc.
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Class Action Announcement for Neumora Therapeutics, Inc. (NMRA): Kessler Topaz Meltzer & Check, LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Neumora Therapeutics, Inc.
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
Neumora Therapeutics, Inc. Shareholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against NMRA
From Robbins LLP
Via GlobeNewswire
Neumora Therapeutics Announces Leadership Transition
From Neumora Therapeutics, Inc.
Via GlobeNewswire
NMRA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.